US Patent Issued to Takeda Pharmaceutical on Oct. 7 for "Compositions and methods of cryopreserving cells" (American, Japanese Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,289, issued on Oct. 7, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Compositions and methods of cryopreserving cells" was invented by Lan Cao (Cambridge, Mass.), Hui-Hsin Chang (Cambridge, Mass.), Jianxin Hu (Cambridge, Mass.), Xi Shi (Cambridge, Mass.) and Yutaka Nishimoto (Shonan, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides, among other things, a cryopreservation medium for cryopreserving mammalian cells, the medium comprising: dimethyl sulfoxide (DMSO), disaccharide, human serum, and IL-7 and/or IL-15. The present disclosure also provides, among other things, a cryopreservation medium for...